title: [Standard of care and new drugs for diffuse large B-cell lymphoma].
authors.forename: Kazuhito
authors.initials: K
authors.lastname: Yamamoto
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D000818:Animals; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D055808:Drug Discovery / Q000639:trends; D044127:Epigenesis, Genetic / Q000235:genetics; D006801:Humans; D000077269:Lenalidomide; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000235:genetics; D051379:Mice; D058990:Molecular Targeted Therapy; D010880:Piperidines; D011239:Prednisolone / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D011720:Pyrazoles / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D018714:Radiotherapy, Adjuvant; D000069283:Rituximab; D013792:Thalidomide / Q000031:analogs & derivatives / Q000627:therapeutic use; D014750:Vincristine / Q000008:administration & dosage; D014751:Vindesine / Q000008:administration & dosage
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines; C571759:R-CHOP protocol; D001761:Bleomycin; C551803:ibrutinib; D000069283:Rituximab; D013792:Thalidomide; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; D000077269:Lenalidomide; D000225:Adenine; D014751:Vindesine; D011241:Prednisone